Clin2
NCT05529342Possibly a fitEnrolling by invitation

Long-term follow-up for a prior gene-cell treatment

HIV

Part of Infections clinical trials.

This study follows people long-term after receiving a specific gene-cell treatment called AGT103-T. It helps researchers check long-term safety and outcomes, which can guide future care for others.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
7 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You previously received AGT103-T through the sponsor’s earlier AGT-HC168 study
  • You agree to participate by signing and dating a consent form for long-term follow-up

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05472649Enrolling by invitation
Long-term follow-up after gene-modified cell therapy

This study checks your health over time after you previously received gene-modified cell therapy in a Sorrento-sponsored trial. It helps researchers understand long-term safety and outcomes and may lead to better care for future patients.

Philadelphia, Pennsylvania
NCT03000244Recruiting
Long-term follow-up after stem cell or gene therapy

This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.

Bethesda, Maryland
NCT04266093Enrolling by invitation
Gene therapy follow-up for adults previously treated at NCI

This study is a follow-up check for people who were previously enrolled in certain NCI gene therapy treatment studies. It helps the research team monitor long-term effects and outcomes after treatment.

Bethesda, Maryland
NCT01492036Recruiting
Long-term follow-up for people who received gene therapy

This study follows people for many years after they receive gene therapy (a treatment that uses lab-made genetic material). It mainly checks long-term safety and health outcomes and may help doctors understand how gene therapy works over time.

Houston, Texas
NCT05713214Recruiting
Long-term follow-up after a gene-modified cell treatment

This study checks long-term health after receiving a gene-modified cell therapy through a St. Jude study. It helps doctors understand the treatment’s lasting effects and safety over time.

Memphis, Tennessee
NCT06798298Recruiting
Long-term safety study of gene modified T cell treatment

This study is a long-term safety check for people who have already received a gene modified T cell treatment in a previous study sponsored by 2seventy bio or Regeneron Pharmaceuticals. The goal is to monitor your health for years after that treatment to see how well it works and if any side effects appear over time.

Nashville, Tennessee

Hear when a new HIV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.